Conditions Microdosing Patients Presentation 
United Patients Group
AUGUST 22, 2023
As the stigma surrounding medical marijuana continues to fade and scientific research validates its potential health benefits, patients and healthcare providers are exploring novel ways to optimize their cannabis experience. Now, microdosing is making its way into the realm of medical marijuana as well.
MMJ Recs
JANUARY 17, 2024
As the legal landscape surrounding cannabis continues to evolve, an increasing number of arthritis patients are turning to this plant for potential relief. How Medical Marijuana Can Help Arthritis Patients Medical marijuana holds significant promise in providing relief and improving the quality of life for arthritis patients.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
CannaTech
OCTOBER 8, 2018
In a perfect world, patients would have honest conversations with their family doctors about cannabis. Times have changed, however, and patients are finding success in various forms of cannabis medication and even treating serious conditions, often where traditional medicine has failed. Hurdles in Healthcare.
Veriheal
MARCH 20, 2023
Using psilocybin in small doses, or microdosing, has been shown to aid in the treatment of various mental health issues, including anxiety, depression, PTSD, and obsessive-compulsive disorder. Both Colorado and Oregon allow patients to take psilocybin under the supervision of regulated and licensed “healing centers.” Minnesota Rep.
Veriheal
JUNE 15, 2021
Psychologists and other medical professionals have long warned against the potential impact of cannabis on the brain, including presenting with psychosis as a result. Psychosis is a severe mental condition that greatly impacts the way the brain processes information causing one to break from reality.
Cannabis Law Report
DECEMBER 2, 2021
IGC) is excited to present preliminary positive secondary end point findings from its Phase 1 clinical trial for IGC-AD1. Over 70% of these patients face one or more debilitating symptoms, including anxiety, depression, and agitation (Mendez, 2021). The trial included three cohorts, with 12 patients in each cohort. POTOMAC, Md.–(BUSINESS
The Cannigma
AUGUST 29, 2021
The AARP, explaining its 2019 policy change, stated that its decision was based on “the growing body of research suggesting marijuana may be helpful in treating certain medical conditions and symptoms.”. If you live in a state that only has a medical cannabis card, then you’ll need to become a licensed patient.
Expert insights. Personalized for you.
80 
Let's personalize your content